HERON THERAPEUTICS, INC. /DE/ Disposal Group, Including Discontinued Operation, Revenue
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Disposal Group, Including Discontinued Operation, Revenue of $0 for the 24-month period ending 2013-12-31, per its 10-K filed 2014-03-07.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2014-03-07
- HERON THERAPEUTICS, INC. /DE/ disposal group, including discontinued operation, revenue for fiscal 2013 was $0.00.
- HERON THERAPEUTICS, INC. /DE/ disposal group, including discontinued operation, revenue for fiscal 2012 was $0.00.
- HERON THERAPEUTICS, INC. /DE/ disposal group, including discontinued operation, revenue for fiscal 2011 was $0.00.
- HERON THERAPEUTICS, INC. /DE/ disposal group, including discontinued operation, revenue for fiscal 2010 was $0.00.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 12 month | Disposal Group, Including Discontinued Operation, Revenue 24 month |
|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-07 | $0.00 10-K · filed 2014-03-07 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-01 | $0.00 10-K · filed 2014-03-07 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-01 | |
| 2010-12-31 | $0.00 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |